---
figid: PMC6707069__nihms-1536112-f0008
figlink: pmc/articles/PMC6707069/figure/F8/
number: Figure 8
caption: 'Influence of extracellular HA in erlotinib efficacy using a reductionist
  3D glioblastoma model. The epidermal growth factor receptor (EGFR) signaling pathway
  regulates growth, survival and proliferation in GBM through three main signaling
  pathways: JAK/STAT, PI3K/mTOR and Ras/ERK. The addition of erlotinib, together with
  the inhibition of extracellular HA receptor (CD44), downregulates STAT3 phosphorylation,
  only in EGFR+ (GBM12) cells. HA microenvironment also decreases erlotinib faculty
  to stop cell motility in these cells, compared to control, but does not influence
  ERK phosphorylation. PDGFRβ expression is enhanced in GBM6 vIII, upon EGFR inhibition.'
pmcid: PMC6707069
papertitle: Hyaluronic acid-functionalized gelatin hydrogels reveal extracellular
  matrix signals temper the efficacy of erlotinib against patient-derived glioblastoma
  specimens.
reftext: Sara Pedron, et al. Biomaterials. ;219:119371-119371.
pmc_ranked_result_index: '56538'
pathway_score: 0.9568533
filename: nihms-1536112-f0008.jpg
figtitle: Influence of extracellular HA in erlotinib efficacy using a reductionist
  3D glioblastoma model
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6707069__nihms-1536112-f0008.html
  '@type': Dataset
  description: 'Influence of extracellular HA in erlotinib efficacy using a reductionist
    3D glioblastoma model. The epidermal growth factor receptor (EGFR) signaling pathway
    regulates growth, survival and proliferation in GBM through three main signaling
    pathways: JAK/STAT, PI3K/mTOR and Ras/ERK. The addition of erlotinib, together
    with the inhibition of extracellular HA receptor (CD44), downregulates STAT3 phosphorylation,
    only in EGFR+ (GBM12) cells. HA microenvironment also decreases erlotinib faculty
    to stop cell motility in these cells, compared to control, but does not influence
    ERK phosphorylation. PDGFRβ expression is enhanced in GBM6 vIII, upon EGFR inhibition.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - CD44
  - AKT2
  - AKT3
  - AKT1
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - MAP2K1
  - MAP2K2
  - HRAS
  - KRAS
  - NRAS
  - PTEN
  - STAT3
  - MAPK3
  - MAPK1
  - PDGFRB
  - PDGFRA
  - erlotinib
  - NA
genes:
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: CD44
  symbol: CD44
  source: hgnc_symbol
  hgnc_symbol: CD44
  entrez: '960'
- word: P13K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: P13K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: P13K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: P13K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: P13K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: P13K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: P13K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: P13K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: P13K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: P13K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: P13K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Ras/MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Ras/MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Ras/MEK
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras/MEK
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras/MEK
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: P13K/AktRas/MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: P13K/AktRas/MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
chemicals:
- word: erlotinib
  source: MESH
  identifier: C400278
- word: NA
  source: MESH
  identifier: C043348
diseases: []
---
